Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial (Q34658901)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Domenico Bonamonte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Massimo Milani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Alessia Marseglia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Fabio Agostinis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Antonio Barcella

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Mario Puviani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

GianLuigi Marseglia

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

1 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Allergy & Immunology

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

271-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

Eczema and ceramides: an update.

14 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Moisturizers for patients with atopic dermatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Barrier repair therapy in atopic dermatitis: an overview

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Isoleucine/leucine2 is essential for chemoattractant activity of beta-defensin Defb14 through chemokine receptor 6.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Abnormal skin barrier in the etiopathogenesis of atopic dermatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

The skin: an indispensable barrier

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Filaggrin in atopic dermatitis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

An essential amino acid induces epithelial beta -defensin expression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Topical corticosteroids: back to basics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

The natural course of eczema from birth to age 7 years and the association with asthma and allergic rhinitis: a population-based birth cohort study.

7 July 2018

1 reference

Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis.

21 January 2018

1 reference

Albumin and amino acids upregulate the expression of human beta-defensin 1.

21 January 2018

1 reference

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.

21 January 2018

1 reference

The value of SCORAD and beyond. Towards a standardized evaluation of severity?

21 January 2018

1 reference

Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective.

21 January 2018

1 reference

Quality of life of parents living with a child suffering from atopic dermatitis before and after a 3-month treatment with an emollient.

21 January 2018

1 reference

21 January 2018

1 reference

A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260143

Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity

26 October 2018

1 reference

The natural history of eczema from birth to adult life: a cohort study

21 January 2018

1 reference

A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis

21 January 2018

1 reference

12 December 2020

Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

1 reference

12 December 2020

Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications

1 reference

12 December 2020

Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?

1 reference

12 December 2020

Pharmacological properties of rhamnose-rich polysaccharides, potential interest in age-dependent alterations of connectives tissues

1 reference

12 December 2020

The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study

1 reference

12 December 2020

Moisturizers: reality and the skin benefits

1 reference

12 December 2020

Identifiers

DOI

10.1111/PAI.12185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

PubMed publication ID

24750568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750568%20AND%20SRC:MED&resulttype=core&format=json